Skip to main content
Stephen Bradford

Stephen Bradford

Patient advocate for NTRK fusion-positive non-small cell lung cancer; shift coordinator at a steel mill in Mobile, Alabama.

Jul 27, 2026

4:39
And you're here today, and you'd shared with me before, but maybe for our audience, what did those biomarker tests come back showing?
4:51
So I had read the report, but I was having a hard time understanding a lot of it, but I did look at some of the present characteristics of my tissue sample.
5:06
So it did mention that I had a NTRK1 fusion, and I didn't know what that was.
5:13
So we started looking into that and wasn't really finding very much information on what that was.
5:22
And I had a second opinion.
5:25
done before my biopsy for that.
5:30
And both doctors did say it was, I was looking at starting chemo and I actually did have one chemo treatment, not the full treatment, just one session.
7:33
And when you went into that first visit, you know, where they're relaying the genotyping results, you know, what do they tell you about, you know, NTRK and NTRK inhibitors and what you might experience when you start on these drugs?

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.